Showing results (421-430 of 490) with videos related to

Sort By:
Pageof 49
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Tumor necrosis factor alpha modifies resistance to interferon alpha in vivo: first clinical dataT Moritz, O Kloke, M Nagel-Hiemke, et al.
Wiener Klinische Wochenschrift|March 24, 2000
[Glomus caroticum chemodectoma. Review on current diagnosis and therapy]M Muhm, P Polterauer, W Gstöttner, et al.
British Journal of Haematology|August 1, 1992
Combination therapy with interferon alpha-2b plus low-dose interferon gamma in pretreated patients with Ph-positive chronic myelogenous leukaemiaU B Wandl, O Kloke, M Nagel-Hiemke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Dendritic cell vaccination in medullary thyroid carcinomaAnton Stift, Monika Sachet, Rubina Yagubian, et al.
The Journal of Pathology|June 2, 2011
Expression of hypoxia-associated proteins in sporadic medullary thyroid cancer is associated with desmoplastic stroma reaction and lymph node metastasis and may indicate somatic mutations in the VHL geneOskar Koperek, Oliver Bergner, Bettina Pichlhöfer, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 1, 1997
Effect of successful parathyroidectomy on hematopoietic progenitor cells and parameters of red blood cells in patients with primary hyperparathyroidismH Kotzmann, C Abela, J Heindl, et al.
World Neurosurgery|November 26, 2023
Current Aspects of Intraoperative High-Field (3T) Magnetic Resonance Imaging in Pediatric Neurosurgery: Experiences from a Recently Launched Unit at a Tertiary Referral CenterKarl Roessler, Fabian Winter, Barbara Kiesel, et al.
Journal of Internal Medicine|October 1, 1995
The value of lymph node dissection in hereditary medullary thyroid carcinoma: a retrospective, European, multicentre studyH Dralle, G F Scheumann, C Proye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Value of peptide receptor scintigraphy using (123)I-vasoactive intestinal peptide and (111)In-DTPA-D-Phe1-octreotide in 194 carcinoid patients: Vienna University Experience, 1993 to 1998M Raderer, A Kurtaran, M Leimer, et al.
American Journal of Hematology|September 1, 1995
Clinical and histological features retain their prognostic impact under interferon therapy of CML: a pilot studyJ Thiele, H M Kvasnicka, N Niederle, et al.
Pageof 49